PXN and cancer: Despite these known roles, more in-depth research is required to elucidate paxillin’s specific contributions to epithelial cell–cell junctions under physiological and pathological conditions, such as during cancer metastasis, where epithelial-to-mesenchymal transition (EMT) disrupts junction integrity.